Belly Fat, Diabetes and Drinking Doubles Liver Disease Risk
The research, published recently in the journal Clinical Gastroenterology and Hepatology, found that people with belly fat or ...
Study connects loneliness and social isolation to non-alcoholic fatty liver disease risk
Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according ...
The Lancet1h
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...
cnbctv1814h
Shilpa Medicare secures CDSCO’s nod for fatty liver drug, shares spike 8%
Non-alcoholic fatty liver disease (NAFLD) affects nearly 19 crore people in India and about a quarter of the world’s ...
Shilpa Medicare receives CDSCO approval for its IND - Nor Ursodeoxycholic Acid Tablets 500 mg
Shilpa Medicare announces the approval of its IND - Nor Ursodeoxycholic Acid Tablets 500 mg, by the Subject Expert Committee of CDSCO. The Committee has further recommended grant of marketing ...
Can fatty liver be reversed with aerobic exercises? The Liver Doc shares workout plan
The Liver Doc shared in a new video that aerobic exercises are essential to reverse NAFLD, stating it is preventable and ...
Hosted on MSN7h
HDL vs. LDL Cholesterol: What’s the Difference?
LDL and HDL are two forms of cholesterol associated with heart health. Keeping them within an optimal range reduces your risk ...
The Lancet20h
Alcohol and cancer risk: bridging the awareness gap
Each year in the USA, alcohol use contributes to nearly 100 000 new cancer cases and 20 000 deaths from cancer, according to ...
‘In cirrhosis patients…’: Expert on why ‘black, unsweetened’ coffee is a must for liver health
Coffee is more than just a morning pick-me-up — it might be one of the simplest ways to protect your liver. According to Dr ...